KHA-CARI Guideline: use of iron in chronic kidney disease patients.
نویسندگان
چکیده
a. That therapeutic iron be used to correct diagnosed iron deficiency (1D). b. Parenteral iron (intravenous) is administered in preference to oral iron to correct iron deficiency. As it is more likely to: • achieve target haemoglobin (Hb) levels (1B), • maintain ferritin and transferrin saturation (%TSAT) at target ranges (1C), • reduce erythropoiesis stimulating agent (ESA) dose requirements (1C) and • have fewer adverse reactions (1C).
منابع مشابه
International treatment guidelines for anaemia in chronic kidney disease - what has changed?
ne ea no five stages O in nine Australians has chronic kidney disse (CKD),1 although the condition may often t be recognised in primary care.2 There are of CKD, ranging from Stage 1, in which patients have normal renal function but urinary abnormalities, structural abnormalities or genetic traits pointing to kidney disease, through to Stage 5, in which patients have end-stage disease.1 Although...
متن کاملKHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of End-Stage Kidney Disease.
those that are being considered as potential kidney donors, need to be carefully screened and excluded from having ADPKD (KHA-CARI ADPKD Guidelines: Genetics, Imaging, and Screening subtopics), prior to living donor transplantation. Nephrectomy of a polycystic kidney prior to the time of transplantation may be required due to insufficient intra-abdominal space for the new allograft. Nephrectomy...
متن کاملKHA-CARI commentary on the KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease.
Due to the markedly accelerated risks of cardiovascular disease for people who have chronic kidney disease (CKD), lipid-lowering treatment represents a potentially effective intervention to reduce cardiovascular events, including death from cardiovascular disease. However, existing randomized trials have been inconsistent about whether statin therapy is beneficial for all patients with CKD, par...
متن کاملKHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Monitoring Disease Progression.
a. We do not recommend performing serial ultrasound, renal computed tomography, or magnetic resonance imaging for monitoring disease progression, unless there are other clinical reasons for repeating these tests (eg, hematuria, pain, fever) (1B) b. We suggest using renal function (ie, estimated glomerular filtration rate and albuminuria) rather than imaging to monitor disease progression (2B) c...
متن کاملKHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Psychosocial Care.
! Explore and validate patient concerns and frustrations about the unpredictability, volatility, and intensity of chronic renal pain. ! Provide strategies and counseling on how to manage the psychological, emotional, and lifestyle impact of pain; and to limit its interference with lifestyle. Behavioral therapy, peer support, emotional disclosure, and online programs have been found to be effect...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Nephrology
دوره 18 12 شماره
صفحات -
تاریخ انتشار 2013